KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Other Accumulated Expenses (2016 - 2025)

Encompass Health (EHC) has disclosed Other Accumulated Expenses for 17 consecutive years, with $289.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses rose 17.82% year-over-year to $289.6 million, compared with a TTM value of $289.6 million through Dec 2025, up 17.82%, and an annual FY2025 reading of $289.6 million, up 17.82% over the prior year.
  • Other Accumulated Expenses was $289.6 million for Q4 2025 at Encompass Health, down from $558.7 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $611.2 million in Q2 2022 and bottomed at $177.3 million in Q4 2021.
  • Average Other Accumulated Expenses over 5 years is $376.0 million, with a median of $425.0 million recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses dropped 18.78% in 2021, then skyrocketed 31.16% in 2024.
  • Year by year, Other Accumulated Expenses stood at $177.3 million in 2021, then increased by 2.14% to $181.1 million in 2022, then grew by 3.48% to $187.4 million in 2023, then soared by 31.16% to $245.8 million in 2024, then rose by 17.82% to $289.6 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for EHC at $289.6 million in Q4 2025, $558.7 million in Q3 2025, and $525.9 million in Q2 2025.